# Pharma Equipment Surface Area Calculation for Cleaning Validation, MACO & Solvent Quantity Requirements: Reactors, ANFDs, Multi-Mills & Synthesis Trains

# 1. Introduction: Why Surface Area Precision is Critical in Cleaning Validation

In multipurpose Active Pharmaceutical Ingredient (API) and solid dosage manufacturing facilities, cross-contamination between successive product campaigns is one of the most heavily scrutinized areas during regulatory audits (FDA 21 CFR Part 211.67, EU GMP Annex 15, PIC/S PI 006-3, and ICH Q7).

The scientific benchmark for assessing cleaning efficacy is the Maximum Allowable Carryover (MACO)—the maximum quantity of a previous active drug substance allowed to remain on shared equipment surfaces without posing a toxicological or therapeutic risk in the subsequent product batch.

However, calculating the Allowable Surface Residue Limit ($L_{shared}$ in $\mu\text{g/cm}^2$), setting analytical swab action limits ($M_{swab}$), and determining the cleaning rinse solvent volume ($V_{solvent}$) strictly depend on knowing the exact total internal wetted surface area ($A_{total}$) of the equipment train. Over-estimating surface area produces falsely high residue limits, risking cross-contamination; under-estimating surface area results in unnecessary cleaning cycles, excessive solvent waste, and extended downtime.

# 2. Equipment Surface Area Vectors & MACO Sizing Architecture

The engineering layout below illustrates the wetted surface area components for three core pharmaceutical unit operations—Chemical Reactors, Agitated Nutsche Filter Dryers (ANFD), and Multi-Mills—along with the APIC / FDA MACO calculation framework:

Interactive Engineering Tool: Automatically compute equipment surface areas, MACO limits, and cleaning solvent quantities using our interactive Pharma Equipment Surface Area & Cleaning Validation Calculator.

# 3. Detailed Equipment Surface Area Geometric Formulas

# 3.1 Jacketed Chemical Batch Reactor (SS316L / Glass-Lined)

In a batch reactor, the total internal wetted surface area ($A_{reactor}$) is the sum of the cylindrical shell, top and bottom dished heads, agitator shaft, impeller blades, baffles, and nozzles:

# A. Cylindrical Shell:

Where $D$ is the inside diameter and $H_{cyl}$ is the straight tan-to-tan shell height.

# B. Dished Heads (Top & Bottom):

The surface area of formed dished heads depends on geometry:

• 2:1 Semi-Ellipsoidal Head (Standard Industrial API Reactor):

• Torispherical Head (Klöpper Type, $r_k = 0.1D, R = D$):

• Hemispherical Head:

• Flat Flanged / Conical Bottom:

# C. Agitator Shaft & Multi-Tier Impeller Blades:

• Shaft Area:

• Pitched Blade Turbine (PBT) / Hydrofoil / Retreat Curve (RCI):

(Rule of thumb for standard dual PBT: $A_{impeller,total} \approx 0.45 - 0.60 \cdot D^2$ per tier)

• Anchor Impeller (Close-Clearance):

# D. Baffles & Internal Nozzles:

• Baffles (3 or 4 Beaver-Tail / Flat Blades):

• Nozzle Necks & Dip Legs:

# 3.2 Agitated Nutsche Filter Dryer (ANFD)

An ANFD features a wide-diameter low-height cylindrical shell, a heated porous sintered filter base plate, S-curved hollow heated agitator blades, a side discharge plug door, and internal hydraulic bellows:

• Filter Base Plate Area (Including Sintered Wire Mesh & Support Rings):

• S-Curved Hollow Heated Agitator Blade (Top face, Bottom face, and Heated leading/trailing edges):

• Side Cake Discharge Port:

• Agitator Shaft Bellows (Protective SS Bellows):

# 3.3 Milling & Size Reduction Equipment (Multi-Mill / Co-Mill)

For dry powder milling, all internal product-contact surfaces must be quantified:

• Conical Feed Hopper (Frustum of a Cone):

Where $R_1$ is the top inlet radius, $R_2$ is the bottom discharge radius, and $H_{hopper}$ is the cone height.

• Milling Chamber Housing:

• Rotor Impeller (12 High-Speed Knife/Impact Blades):

• Perforated Screen Mesh Cylinder:

• Discharge Chute:

# 3.4 Process Centrifuges & Transfer Piping

• Peeler / Vertical Centrifuge Basket & Curb:

• Process Transfer Piping Loops & Hoses:

# 4. Maximum Allowable Carryover (MACO) Formulations (APIC / FDA / EMA)

Per the APIC Guide on Aspects of Cleaning Validation in API Plants, MACO is evaluated across three scientific criteria. The most stringent (lowest) value governs the validation acceptance protocol:

# 4.1 Criterion 1: Therapeutic Daily Dose (1/1000th Dose Rule)

No more than $0.1\%$ ($1/1000\text{th}$) of the minimum therapeutic daily dose of the previous product should be carried over into the maximum daily dose of the subsequent product:

Where:

• $TDD_{prev}$ = Minimum daily therapeutic dose of previous API (mg/day)
• $MBS_{next}$ = Minimum batch size of subsequent product (mg or kg)
• $TDD_{next}$ = Maximum daily therapeutic dose of subsequent product (mg/day)
• $SF$ = Safety Factor ($1,000$ for oral solid dose APIs; $5,000 - 10,000$ for potent, injectable, or ophthalmic formulations)

# 4.2 Criterion 2: 10 ppm Default Toxicological Limit

Not more than $10\text{ ppm}$ ($10\text{ mg/kg}$) of the previous active ingredient is permitted in the subsequent batch:

# 4.3 Criterion 3: Health-Based Exposure Limit (ADE / PDE per EMA Guidelines)

Based on toxicological Permitted Daily Exposure (PDE) or Acceptable Daily Exposure (ADE) determined from animal NOAEL / LOAEL data:

# 5. Allowable Surface Limits & Swab Action Limits

Once the governing MACO ($MACO_{gov}$ in mg) is selected:

# 5.1 Shared Surface Carryover Limit ($L_{shared}$)

# 5.2 Analytical Swab Sample Action Limit ($M_{swab}$)

When taking swab samples using a standard sampling template ($25\text{ cm}^2$ for $5\times 5\text{ cm}$ or $100\text{ cm}^2$ for $10\times 10\text{ cm}$):

Where $\text{Recovery}\%$ is the experimentally validated swab extraction recovery ($80 - 95\%$).

# 6. Cleaning Solvent Quantity Requirements ($V_{solvent}$)

Determining the proper solvent volume ($V_{solvent}$ in Liters) for cleaning validation rinses requires balancing physical hydraulic wetting against analytical instrument sensitivity:

# 6.1 Method A: Analytical Detection Limit ($V_{solvent,max}$)

To ensure that any residue at the MACO limit will produce a concentration in the final rinse that is above the analytical method's Limit of Quantitation ($LOQ$):

# 6.2 Method B: Minimum Hydraulic Surface Wetting Volume ($V_{solvent,min}$)

For dynamic spray balls and CIP orbital nozzles, adequate liquid film cascade requires:

Where $q_{wetting} = 2.5 - 5.0\text{ L/m}^2$ of equipment surface area.

# 6.3 Method C: Agitation Boil-Up / Reflux Wash Volume

For batch synthesis reactors, a liquid charge of $15 - 20\%$ of nominal volume is required to completely submerge the bottom agitator blade and generate vigorous vapor reflux across the upper shell, dished head, and vapor line.

# 7. Comprehensive Worked Engineering Case Study: Multi-Equipment API Synthesis Train

# 7.1 Manufacturing Train Description:

A dedicated campaign of Previous API (Product A) is completed, followed by changeover to Next API (Product B) across a 5-unit shared synthesis train:

• Reactor (R-101): $5.0\text{ KL}$ Jacketed SS316L Reactor ($D = 1.60\text{ m}, H = 2.00\text{ m}$, 2:1 Ellipsoidal Heads, Dual PBT Impellers) $\implies A_1 = \mathbf{24.80\text{ m}^2}$
• Centrifuge (CF-101): $1200\text{ mm}$ Vertical Peeler Centrifuge $\implies A_2 = \mathbf{7.20\text{ m}^2}$
• Filter Dryer (FD-601): $3.0\text{ m}^2$ Agitated Nutsche Filter Dryer ($D = 1.95\text{ m}, H = 1.20\text{ m}$) $\implies A_3 = \mathbf{18.50\text{ m}^2}$
• Multi-Mill (MM-101): High-Speed Rotor & Perforated Screen Mill $\implies A_4 = \mathbf{1.60\text{ m}^2}$
• Transfer Piping (PL-101): $40\text{ m}$ of 2" NB SS316L Piping $\implies A_5 = \mathbf{6.30\text{ m}^2}$

# 7.2 Toxicological & Batch Parameters:

• Product A (Previous): Min Daily Dose $TDD_{prev} = 10\text{ mg/day}$, $PDE_{prev} = 0.05\text{ mg/day}$, Safety Factor $SF = 1,000$
• Product B (Next): Min Batch Size $MBS_{next} = 500\text{ kg}$, Max Daily Dose $TDD_{next} = 25\text{ mg/day}$
• Swab Template: $25\text{ cm}^2$ ($5\times 5\text{ cm}$), Analytical Recovery $= 85\%$
• Analytical HPLC LOQ: $0.50\text{ ppm}$ ($0.50\text{ mg/L}$)

# 7.3 Step-by-Step MACO & Cleaning Sizing:

1. Therapeutic Dose-Based MACO:

2. 10 ppm Default MACO:

3. PDE Health-Based MACO:

4. Governing Acceptance Limit:

5. Allowable Surface Carryover Limit ($L_{shared}$):

6. Swab Sample Action Limit ($M_{swab}$):

7. Cleaning Solvent Quantity Requirements ($V_{solvent}$):
   • Method A (Maximum volume for $0.5\text{ ppm}$ LOQ):

• Method B (Minimum hydraulic wetting volume at $3.5\text{ L/m}^2$):

• Method C (Operational Recommended Charge):
  • For Reactor R-101 ($15\%$ boil-up heel): $750\text{ Liters}$
  • For ANFD FD-601 (base rinse & spray): $300\text{ Liters}$
  • For Centrifuge & Lines: $150\text{ Liters}$
  • Total Recommended Train Rinse Solvent: $\mathbf{1,200\text{ Liters}}$ (producing a safe analytical concentration of $\approx 0.83\text{ ppm} > LOQ$).

# 8. Summary of Best Practice Engineering Rules

1. Include All Internal Fixtures: Never calculate simple cylinder volume; always include impeller blades, bottom valves, dip legs, baffles, and nozzles.
2. Apply Worst-Case Train Envelope: If a piece of equipment is shared between multiple synthesis routes, use the smallest subsequent batch size ($MBS_{min}$) and most potent previous API.
3. Validate Swab Recovery: Perform lab coupon recovery studies ($SS316L$, Glass, PTFE) across three concentration levels ($50\%$, $100\%$, and $150\%$ of swab limit).
4. Balance Solvent Volumes: Verify that the solvent rinse volume produces a concentration well above the analytical method's LOQ while remaining below the MACO threshold.

# 9. Governing Quality & Regulatory Standards

• APIC (Active Pharmaceutical Ingredients Committee): Guidance on Aspects of Cleaning Validation in API Plants (May 2014).
• FDA 21 CFR Part 211.67: Equipment Cleaning and Maintenance.
• FDA Guidance: Guide to Inspections of Validation of Cleaning Processes (7/93).
• EMA/CHMP/CVMP/SWP/169430/2012: Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities.
• PIC/S PI 006-3: Validation Master Plan, Installation and Operational Qualification, Non-Sterile Process Validation, Cleaning Validation.
• ASTM E3106-18e1: Standard Guide for Science-Based and Risk-Based Cleaning Process Development and Validation.
• ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.

# Applicable Engineering Standards & Codes Used

The engineering methodologies, design correlations, and safety criteria detailed in this article adhere to the following international standards and industry codes:

• US FDA 21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals
• EU GMP Annex 1: Manufacture of Sterile Medicinal Products
• ISPE Baseline Pharmaceutical Engineering Guide (Vol 1-7: Bulk Active Pharmaceutical Ingredients, Water & Steam Systems): ISPE Baseline Pharmaceutical Engineering Guide (Vol 1-7: Bulk Active Pharmaceutical Ingredients, Water & Steam Systems)
• WHO Technical Report Series No. 961: Supplementary Guidelines on Good Manufacturing Practices for Heating, Ventilation and Air Conditioning